Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082966
Status:
COMPLETED
Last Update Posted:
2015-12-04
First Post:
2004-05-14
Brief Title:
Bortezomib in Treating Patients With Relapsed or Refractory Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Adult Hodgkin Lymphoma |
| Adult Lymphocyte Depletion Hodgkin Lymphoma |
| Adult Mixed Cellularity Hodgkin Lymphoma |
| Adult Nodular Sclerosis Hodgkin Lymphoma |
Keywords: